Hydrocortisone in Tennis Elbow—A Controlled Series [<i>Abridged</i>]

Baily, R. A. J.; Brock, Breanna

doi:10.1177/003591575705000605

Cited by 12 publications

(10 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Reviewing 248 abstracts and 29 full papers, resulted in inclusion of 12 articles (Bär et al, 1997;Day et al, 1978;Erturk et al, 1997;Freeland and Gribble, 1954;Haker and Lundeberg, 1993;Halle, 1986;Hay et al, 1999;Murley and Lond, 1954;Oksenberg et al, 1998;Price et al, 1991;Saartok and Eriksson, 1986;Verhaar et al, 1996). Screening the references of all retrieved RCTs and reviews resulted in one additionally eligible RCT (Baily and Brock, 1957).…”

Section: Study Selectionmentioning

confidence: 99%

“…In almost half of the studies, the duration of the elbow complaints at randomisation was not specified (Baily and Brock, 1957;Freeland and Gribble, 1954;Halle, 1986;Murley and Lond, 1954;Oksenberg et al, 1998;Saartok and Eriksson, 1986). All other studies included a mixed population of patients with acute, subacute and chronic lateral epicondylitis (Bär et al, 1997;Day et al, 1978;Erturk et al, 1997;Haker and Lundeberg, 1993;Hay et al, 1999;Price et al, 1991;Verhaar et al, 1996).…”

Section: Study Characteristicsmentioning

confidence: 99%

“…Only six studies performed an intermediate (6 weeks-6 months) or long-term ($6 months) outcome assessment (Freeland and Gribble, 1954;Price et al, 1991;Baily and Brock, 1957;Haker and Lundeberg, 1993;Hay et al, 1999;Verhaar et al, 1996). The results are presented in Table 3.…”

Section: Intermediate and Long Term Effectivenessmentioning

confidence: 99%

“…Eight studies provided information on the adverse effects of corticosteroid injections, such as facial flushes, post injection pain and local skin atrophy (Bär et al, 1997;Baily and Brock, 1957;Haker and Lundeberg, 1993;Hay et al, 1999;Saartok and Eriksson, 1986;Price et al, 1991;Murley and Lond, 1954;Verhaar et al, 1996). Post injection pain (11-58%) and local skin atrophy (17-40%) was reported in four studies, but irrespectively whether patients had received a corticosteroid injection, or control treatment (Price et al, 1991;Haker and Lundeberg, 1993;Hay et al, 1999;Saartok and Eriksson, 1986).…”

Section: Adverse Effectsmentioning

confidence: 99%

See 3 more Smart Citations

Corticosteroid injections for lateral epicondylitis: a systematic review

Smidt

Assendelft

Windt

et al. 2002

Pain

299

141

View full text Add to dashboard Cite

Patients with lateral epicondylitis (tennis elbow) are frequently treated with corticosteroid injections, in order to relieve pain and diminish disability. The objective of this review was to evaluate the effectiveness of corticosteroid injections for lateral epicondylitis. Randomised controlled trials (RCTs) were identified by a highly sensitive search strategy in six databases in combination with reference tracking. Two independent reviewers selected and assessed the methodological quality of RCTs that included patients with lateral epicondylitis treated with corticosteroid injection(s), and reported at least one clinically relevant outcome measure. Standardised mean differences were computed for continuous data and relative risks (RR) for dichotomous data. A best-evidence synthesis was conducted, weighting the studies with respect to their internal validity, statistical significance, clinical relevance, and statistical power. Thirteen studies consisting of 15 comparisons were included in the review, evaluating the effects of corticosteroid injections compared to placebo injection (n=2), injection with local anaesthetic (n=5), another conservative treatment (n=5), or another corticosteroid injection (n=3). Almost all studies had poor internal validity scores. For short-term outcomes (or=6 months), no statistically significant or clinically relevant results in favour of corticosteroid injections were found. Although the available evidence shows superior short-term effects of corticosteroid injections for lateral epicondylitis, it is not possible to draw firm conclusions on the effectiveness of injections, due to the lack of high quality studies. No beneficial effects were found for intermediate or long-term follow-up. More, better designed, conducted and reported RCTs with intermediate and long-term follow-up are needed.

show abstract

Section: Study Selectionmentioning

confidence: 99%

Section: Study Characteristicsmentioning

confidence: 99%

Section: Intermediate and Long Term Effectivenessmentioning

confidence: 99%

Section: Adverse Effectsmentioning

confidence: 99%

See 2 more Smart Citations

Corticosteroid injections for lateral epicondylitis: a systematic review

Smidt

Assendelft

Windt

et al. 2002

Pain

299

141

View full text Add to dashboard Cite

show abstract

“…This review focuses on injection therapy. The most commonly used substance for injection is corticosteroid (CS), which has been used for 60 years 5. Recently developed injection therapies include autologous blood (AB), botulinum toxin A (BT), glycosaminoglycan polysulfate (GSGPS), hyaluronic acid (HYA), prolotherapy (PRO) and autologous platelet-rich plasma (PRP).…”

Section: Introductionmentioning

confidence: 99%

Injection therapies for lateral epicondylalgia: a systematic review and Bayesian network meta-analysis

Dong¹,

Goost²,

Lin

et al. 2015

Br J Sports Med

View full text Add to dashboard Cite

Some commonly used injection therapies can be considered treatment candidates for lateral epicondylalgia, such as botulinum toxin, platelet-rich plasma and autologous blood injection, but corticosteroid is not recommended. Hyaluronate injection and prolotherapy might be more effective, but their superiority must be confirmed by more research. The peppering technique is not helpful in injection therapies.

show abstract